Cheng Ruey-Kuang, Liao Ruey-Ming
Department of Psychology, Research Center for Mind, Brain, and Learning, National Cheng-Chi University Taipei 116, Taiwan, ROC.
Chin J Physiol. 2007 Apr 30;50(2):77-88.
Previous studies have shown that amphetamine significantly alters operant responding on the behavior maintained on a schedule of differential reinforcement of low-rate (DRL). As such, behavioral deficiency of DRL responding has been observed by the drug-induced increase of non-reinforced responses and a leftward shift of inter-response time (IRT) curve on DRL responding in the rat. However, the neurochemical basis for amphetamine-induced DRL behavioral alternations remain to be elucidated. The present study was then designed to examine whether the effects of amphetamine were dependent on dopamine-subtyped receptors, this was carried out by the co-administration of the selective D1 and D2 receptor antagonists, SCH23390 and raclopride respectively. Rats were first trained to perform on DRL 10-sec task and then divided into four groups, which received separate types of double injections before the behavioral session. The four groups were the saline control group, the amphetamine alone group, the dopamine antagonist alone group, and the combination of [corrected] amphetamine and dopamine antagonist group. The saline control group performed DRL responding in an efficient manner with a major index for the peak time of the IRT curve, which was fairly localized within the 10-sec bin throughout the test phase. The subjects injected with amphetamine (1 mg/kg) significantly shortened IRT that led to a leftward shift of IRT curve, which was further revealed by a decreased peak time without significant effectiveness on the peak rate and burst response. Even though the group given SCH23390 or raclopride alone showed profound disruption on DRL behavior by flattening the IRT curve, the co-administration of amphetamine with SCH23390 or raclopride reversed the aforementioned amphetamine-induced behavioral deficiency on DRL task. Together, these results suggest that the dopamine D1 and D2 receptors are involved and important to the temporal regulation of DRL response under psychostimulant drug treatment. Furthermore, this highlights the involvement of the brain dopamine systems in the temporal regulation of DRL behavior performance.
先前的研究表明,苯丙胺能显著改变在低速率差异强化(DRL)时间表上维持的行为的操作性反应。因此,在大鼠中,通过药物诱导的非强化反应增加以及DRL反应的反应间隔时间(IRT)曲线向左移动,观察到了DRL反应的行为缺陷。然而,苯丙胺诱导的DRL行为改变的神经化学基础仍有待阐明。于是,本研究旨在检验苯丙胺的作用是否依赖于多巴胺亚型受体,这是通过分别联合使用选择性D1和D2受体拮抗剂SCH23390和雷氯必利来进行的。大鼠首先接受DRL 10秒任务训练,然后分为四组,在行为实验前接受不同类型的双重注射。这四组分别是生理盐水对照组、单独使用苯丙胺组、单独使用多巴胺拮抗剂组以及苯丙胺和多巴胺拮抗剂联合使用组。生理盐水对照组以高效方式进行DRL反应,IRT曲线峰值时间是主要指标,在整个测试阶段该指标相当集中在10秒的时间段内。注射苯丙胺(1毫克/千克)的受试者显著缩短了IRT,导致IRT曲线向左移动,这进一步表现为峰值时间减少,而对峰值速率和爆发反应无显著影响。尽管单独给予SCH23390或雷氯必利的组通过使IRT曲线变平对DRL行为造成了严重干扰,但苯丙胺与SCH23390或雷氯必利联合使用可逆转上述苯丙胺诱导的DRL任务行为缺陷。总之,这些结果表明多巴胺D1和D2受体参与其中,并且对精神刺激药物治疗下DRL反应的时间调节很重要。此外,这突出了脑多巴胺系统在DRL行为表现的时间调节中的作用。